227 related articles for article (PubMed ID: 32121387)
1. Potential Mechanisms of Cancer-Related Hypercoagulability.
Nasser NJ; Fox J; Agbarya A
Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32121387
[TBL] [Abstract][Full Text] [Related]
2. Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study.
Syrigos K; Grapsa D; Sangare R; Evmorfiadis I; Larsen AK; Van Dreden P; Boura P; Charpidou A; Kotteas E; Sergentanis TN; Elalamy I; Falanga A; Gerotziafas GT
Oncologist; 2018 Nov; 23(11):1372-1381. PubMed ID: 30104289
[TBL] [Abstract][Full Text] [Related]
3. Heparin, heparan sulfate and heparanase in cancer: remedy for metastasis?
Li JP
Anticancer Agents Med Chem; 2008 Jan; 8(1):64-76. PubMed ID: 18220506
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated venous thromboembolism: Burden, mechanisms, and management.
Ay C; Pabinger I; Cohen AT
Thromb Haemost; 2017 Jan; 117(2):219-230. PubMed ID: 27882374
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic Risk from Chemotherapy and Other Cancer Therapies.
Debbie Jiang MD; Alfred Ian Lee MD
Cancer Treat Res; 2019; 179():87-101. PubMed ID: 31317482
[TBL] [Abstract][Full Text] [Related]
6. Deep venous thrombosis.
López JA; Kearon C; Lee AY
Hematology Am Soc Hematol Educ Program; 2004; ():439-56. PubMed ID: 15561697
[TBL] [Abstract][Full Text] [Related]
7. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
Gerotziafas GT; Taher A; Abdel-Razeq H; AboElnazar E; Spyropoulos AC; El Shemmari S; Larsen AK; Elalamy I;
Oncologist; 2017 Oct; 22(10):1222-1231. PubMed ID: 28550032
[TBL] [Abstract][Full Text] [Related]
8. The link between cancer and venous thromboembolism: a review.
Kessler CM
Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S3-7. PubMed ID: 19654481
[TBL] [Abstract][Full Text] [Related]
9. [Risk of venous thromboembolism in cancer patients: Reality, actuality and perspectives].
Gerotziafas GT; Elalamy I
Bull Cancer; 2016 Sep; 103(9):764-75. PubMed ID: 27481723
[TBL] [Abstract][Full Text] [Related]
10. Haemostatic alterations induced by treatment with asparaginases and clinical consequences.
De Stefano V; Za T; Ciminello A; Betti S; Rossi E
Thromb Haemost; 2015 Feb; 113(2):247-61. PubMed ID: 25338526
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in patients with cancer and its relationship to the coagulation cascade and vascular endothelial growth factor.
Dogan M; Demirkazik A
Support Cancer Ther; 2005 Oct; 3(1):28-34. PubMed ID: 18632433
[TBL] [Abstract][Full Text] [Related]
12. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
Palumbo A; Rajkumar SV; Dimopoulos MA; Richardson PG; San Miguel J; Barlogie B; Harousseau J; Zonder JA; Cavo M; Zangari M; Attal M; Belch A; Knop S; Joshua D; Sezer O; Ludwig H; Vesole D; Bladé J; Kyle R; Westin J; Weber D; Bringhen S; Niesvizky R; Waage A; von Lilienfeld-Toal M; Lonial S; Morgan GJ; Orlowski RZ; Shimizu K; Anderson KC; Boccadoro M; Durie BG; Sonneveld P; Hussein MA;
Leukemia; 2008 Feb; 22(2):414-23. PubMed ID: 18094721
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparins and angiogenesis.
Norrby K
APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
15. [Venous thromboembolism and cancer].
Pavic M; Debourdeau P; Aletti M; Farge-Bancel D; Rousset H
Rev Med Interne; 2006 Apr; 27(4):313-22. PubMed ID: 16414153
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in patients with cancer. Part I. Survey of oncology nurses' attitudes and treatment practices for ambulatory settings.
Viale PH; Schwartz RN
Clin J Oncol Nurs; 2004 Oct; 8(5):455-61. PubMed ID: 15515279
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps.
Boone BA; Murthy P; Miller-Ocuin J; Doerfler WR; Ellis JT; Liang X; Ross MA; Wallace CT; Sperry JL; Lotze MT; Neal MD; Zeh HJ
BMC Cancer; 2018 Jun; 18(1):678. PubMed ID: 29929491
[TBL] [Abstract][Full Text] [Related]
18. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.
Kristinsson SY; Björkholm M; Schulman S; Landgren O
Semin Hematol; 2011 Jan; 48(1):46-54. PubMed ID: 21232658
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
